Monitoring of Safety and Tolerance of PICOPREP in Clinical Practice


A Confirmation of Safety, Tolerance and Efficacy of PICOPREP in Clinical Practice.

Full Title of Study: “A Study of PICOPREP in Patients Needing to Clean the Bowel Prior to X-ray Examination, Endoscopy or Surgery”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: February 2015

Arms, Groups and Cohorts

  • PICOPREP treatment
    • PICOPREP powder for oral solution according to standard clinical practice

Clinical Trial Outcome Measures

Primary Measures

  • The Frequency of Adverse Events
    • Time Frame: 2 days
  • The Severity of Adverse Events
    • Time Frame: 2 days

Secondary Measures

  • Treatment efficacy measured by assessment of the quality of colon cleaning
    • Time Frame: 2 days

Participating in This Clinical Trial

Inclusion Criteria

  • Patients eligible for treatment with PICOPREP┬« for bowel cleansing prior to endoscopic examination or surgery Exclusion Criteria:

  • Patients in which prescription of PICOPREP┬« is contraindicated

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Ferring Pharmaceuticals
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Clinical Development Support, Study Director, Ferring Pharmaceuticals

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.